Kim et al., 2021 - Google Patents
Risk of diabetes in subjects with positive fecal immunochemical test: a nationwide population-based studyKim et al., 2021
View HTML- Document ID
- 4593047194485636640
- Author
- Kim K
- Lee H
- Han K
- Moon J
- Hong S
- Kang E
- Lee J
- Soh H
- Koh S
- Im J
- Kim J
- Publication year
- Publication venue
- Endocrinology and Metabolism
External Links
Snippet
Background Positive fecal immunochemical test (FIT) results have been recently suggested as a risk factor for systemic inflammation. Diabetes induces inflammation in the gastrointestinal tract via several ways. We investigated the association between FIT results …
- 206010012601 Diabetes mellitus 0 title abstract description 85
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/062—Gastritis or peptic ulcer disease
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kramer et al. | Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease | |
| Grinstein et al. | Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents | |
| Tseng | Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus | |
| Hirano et al. | High‐rate pulmonary involvement in autoimmune pancreatitis | |
| Caminiti et al. | Chronic urticaria and associated coeliac disease in children: a case–control study | |
| Zhang et al. | Association between serum uric acid to HDL‐cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults | |
| Ho et al. | Change of both endocrine and exocrine insufficiencies after acute pancreatitis in non-diabetic patients: a nationwide population-based study | |
| Besser et al. | Home urine C‐peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes | |
| Song et al. | Association of antiparietal cell and anti-intrinsic factor antibodies with risk of gastric cancer | |
| Kim et al. | Risk of diabetes in subjects with positive fecal immunochemical test: a nationwide population-based study | |
| Yeo et al. | Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis | |
| Baek et al. | Age at diagnosis and the risk of diabetic nephropathy in young patients with type 1 diabetes mellitus | |
| Andalib et al. | Breath hydrogen as a biomarker for glucose malabsorption after roux‐en‐Y gastric bypass surgery | |
| Tseng | Metformin use is associated with a lower incidence of hospitalization for atrial fibrillation in patients with type 2 diabetes mellitus | |
| Park et al. | Association of prediabetes, diabetes, and diabetes duration with biliary tract cancer risk: A nationwide cohort study | |
| Ojeda‐Fernández et al. | Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID‐19 patients with diabetes: a population‐based study in Lombardy | |
| Al‐Omary et al. | The importance and impact of recognizing metabolic Dysfunction‐Associated fatty liver disease in patients with chronic hepatitis C | |
| Yen et al. | Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis | |
| Reutrakul et al. | The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance | |
| Talukdar et al. | Impact of ductal interventions on diabetes in patients with chronic pancreatitis | |
| Yen et al. | Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes | |
| Zhang et al. | Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury | |
| Kim et al. | Long-term effect of the eradication of Helicobacter pylori on the hemoglobin A1c in type 2 diabetes or prediabetes patients | |
| Chiang et al. | Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome | |
| Kabootari et al. | Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study |